Investments

Buyout

Sector expertise

We specialize in four sectors that are poised for robust and sustainable growth – Health & Wellness, the Food Value Chain, Technology, and Business Services – where our private equity expertise gives us a valuable competitive advantage. Ardian provides our portfolio companies with a strategic partner that offers in-depth market experience and an extensive network within the sector.

  • 100+

    investments and over 320 build-ups since 1997

Health-and-Wellness

Health & Wellness

The sector benefits from long-term, secular growth trends such as: an aging population, rapid technological advancements, an increased focus on well-being, and the spread of chronic diseases. Our team invests across the value chain, from drug development to care delivery, identifying opportunities that improve patient outcomes at every stage.

  • €3.8bn

    invested since inception, 20 transactions

Held / Exited
  • Logo Seqens
    Buyout

    Seqens

    France

    Healthcare & life science

    Exited

    Healthcare & life science

    Sequens is a producer of essential chemicals for use in everyday products. The group is structured across 3 divisions: Pharmaceutical & Cosmetics, Performance Chemicals and Mineral Specialties. Seqens is an industry leader across a wide range of products including aspirin, paracetamol, salicylic acid, para-aminophenol, soda ash, sodium bicarbonate, phenol and oxygenated solvents. It targets a set of five resilient and diversified end-markets including pharma & healthcare, food & feed, cosmetics, flavors & fragrances, home care and environment. Seqens serves 750 customers from 14 industrial sites located in Europe and Asia, and employs ~1,600 people.

We appreciate Ardian’s unique support on our growth path that helped us very much to become market leader and position us ideally for future growth.”

Daniel Schustermann Managing Director of Schustermann & Borenstein